Cytonics Corporation

Neutral
BETA

Developing diagnostics and therapeutics for osteoarthritis

Analytics

Raised to Date: $963,196

Aggregate Commitments $
Platform

SeedInvest

Start Date

07/10/2020

Close Date

12/31/2020

Min. Goal

$1,500,000

Max. Goal

$19,000,000

Min. Investment

$1,000

Security Type

Equity - Preferred

Funding Type

RegA+

Valuation

$46,701,000

Weekly Commitments $
Status

Active

Reporting Date

12/02/2020

Days Remaining

28

% of Min. Goal

64%

% of Max. Goal

5%

Likelihood of Max
Avg. Daily Raise

$6,643

# of Investors

530

Momentum
Location
Industry

Healthcare & Pharmaceuticals

Tech Sector

Cytonics Corporation, with a pre-money valuation of $46.7 million, is raising funds on SeedInvest through Reg A+ crowdfunding. The company is a leader in regenerative medicine and has developed innovative therapies for musculoskeletal diseases like osteoarthritis. Cytonics has created an Autologous Platelet Integrated Concentration system concentrating A2M from patients’ blood to treat their own damaged joints. Cytonics Corporation was founded by Gaetano Scuderi and has raised over $15 million in previous rounds of financing. The current round of funding has a minimum raise of $1,500,000 and a maximum raise of $19,000,000, and the funds will be used for GMP production of CYT-108, GLP pre-clinical animal study, Phase 1 human clinical trial, and Phase 2 human clinical trial. Cytonics Corporation has already initiated a pilot pre-clinical study for its lead drug candidate CYT-108 in 2019. It is a biologic therapy modeled after the naturally occurring A2M molecule found in the blood.

Balance Sheet

Cash and Cash Equivalents

$537,592

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$18,417

Loans

$0

Property, Plant and Equipment (PP&E)

$0

Property and Equipment

$0

Total Assets

$1,056,608

Accounts Payable & Accrued Liabilities

$157,633

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$1,061,904

Total Liabilities

$1,219,537

Total Stockholders' Equity

$-162,929

Total Liabilities and Equity

$1,056,608

Statement of Comprehensive Income Information

Total Revenues

$365,169

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$1,119,923

Total Interest Expenses

$0

Depreciation and Amortization

$28,823

Net Income

$-976,922

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: D. Brooks and Associates CPA's, P.A.
Summary of Crowdfunding Raises
Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
12/31/2020 SeedInvest $46,701,000 $963,196 Equity - Preferred Active RegA+
05/18/2019 SeedInvest $32,400,000 $429,344 Convertible Note Confirmed Closed RegCF
Other Deals

UpLyft on Wefunder

UpLyft has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
HealtheMed on Wefunder

HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Biopact on Equifund CFP

Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Cytonics Corporation on SeedInvest
Follow company
Follow Cytonics Corporation on SeedInvest